HealthLynked Corp
HLYK- Exchange
- OTC
- Industry
- Services-Offices & Clinics of Doctors of Medicine
- SEC CIK
- 0001680139
No open-market purchases or sales by HealthLynked Corp insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $222 in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, 0 vs. previous quarter
- 1
- 13F valueReported value at the end of Q2 2026
- $222
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding HLYK, Q2 2026
No superinvestor reported holding HLYK at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by HealthLynked Corp insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 24, 2024 (view filing)4:00 PM ET | Jun 20-24 | 4 days | Rosal DavidChief Financial Officer | PPurchase | +62.0K | $0.0818 | +$5.07K | New position62.0K after | 2 lots |
Top 10 13F holders, Q2 2026
The largest institutional positions in HealthLynked Corp at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Ancora Advisors, LLC | 74 | $222 | 0.00% | 00.0% | Unchanged |